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Epidermal keratinocytes are used as a cell source for autologous and allogenic cell transplant therapy for skin burns. The question
addressedhereistodeterminewhetherthecultureprocessmayinducecellular,molecular,orgeneticalterationsthatmightincrease
the risk of cellular transformation. Keratinocytes from four diﬀerent human donors were investigated for molecular and cellular
parameters indicative of transformation status, including (i) karyotype, (ii) telomere length, (iii) proliferation rate, (iv) epithelial-
mesenchymal transition, (v) anchorage-independent growth potential, and (vi) tumorigenicity in nude mice. Results show that,
despite increased cell survival in one keratinocyte strain, none of the cultures displayed characteristics of cell transformations,
implying that the culture protocol does not generate artefacts leading to the selection of transformed cells. We conclude that the
current protocol does not result in an increased risk of tumorigenicity of transplanted cells.
1.Introduction
In 1975, serial subculture of human keratinocytes was ﬁrst
described in [1]. Clinical application of this discovery was
made possible after the preparation of these cells into epithe-
lial sheets. Since then, cultured autologous and allogenic
epithelia have been produced for treatment of extensive
third-degree burns with good results [2]. Implementation
of strict safety measures for banking allogenic keratinocytes
has allowed minimizing the risks of infections and contam-
inations. However, there is still controversy as to whether
the process of isolating and culturing keratinocytes prior to
transplantation may somehow induce genetic modiﬁcations
or enhance cell stem properties, potentially generating an
increasedriskoftumorigenesiswhichmaybedevelopedafter
transplantation. This question has been particularly diﬃcult
to address due to the lack of consensus on the cellular,
molecular, or genetic parameters for assessing tumorigenic-
ity in cultured keratinocytes. Recent developments on the
knowledge of the sequence of molecular events required
for transformation of primary epithelial cells in vitro have
allowed us to select a set of deﬁned parameters to allow such
an assessment in a series of four independent cultures of
primary keratinocytes.
Thetransformationofprimaryhumancellsisamultistep
process that requires sequential alterations of several well-
described pathways. According to Weinberg and collabora-
tors [3–6], the transformation of primary cultures of epider-
mal cells requires the targeting of at least three mechanisms:
combined inactivation of p53 and Rb pathways, constitutive
activation of telomerase, and oncogenic activation of cell
proliferation. These events have been rarely observed in pri-
mary human epithelial cell cultures. Primary keratinocytes
preserve their capacity to enter replicating senescence asso-
ciated with growth arrest and do not reactivate telomerase
activity [7, 8]. On the other hand, inactivation of p53 and2 Journal of Skin Cancer
Rb pathways or spontaneous activation of Ras pathway have
seldom been observed in such primary cultures, leading
to the concept that human skin keratinocytes are resistant
to transformation in vitro. One of the rare documented
examples of spontaneous immortalization in vitro is the
HaCaT cell line, which is derived from primary culture of
adult skin. This cell line which has acquired mutations in
TP53, is obviously immortal, has a transformed phenotype
in vitro (clonogenic on plastic and in agar) but remains
nontumorigenic in vivo. HaCaT cells, similar to normal ker-
atinocytes, reform an orderly structured and diﬀerentiated
epidermal tissue when transplanted onto nude mice [9].
It should be noted, however, that in primary cell culture,
spontaneous immortalization in vitro is unlikely to occur
during the very short time of culture (maximum 4 passages).
In the case of HaCaT [9], immortalization required long-
term in vitro culture conditions and is associated with
a lag phase. During this phase, cells stop proliferating,
e n l a r g e ,a n dr e m a i ng r o w t ha r r e s t e df o rar e l a t i v e l yl o n g
period (3–6 weeks). Thereafter, islands of small proliferating
cells may appear and continue to grow without further
interruption. Cellular transformation is thus preceded by
an easily detectable phase of senescence associated with
decreased growth rate. Then, in the case of transformation,
epithelial cells undergo morphological changes and increase
their growth rate [10] to form deﬁned colonies.
In the present study, we aimed at determining whether
molecular, genetic, or cellular changes may occur during
the short phase of primary culture of keratinocytes in vitro,
which may not lead to a detectable culture phenotype but
nevertheless aﬀect the long-term tumorigenic potential of
the cells. We have therefore used a range of approaches
to check whether events related to the sequence of experi-
mental transformation of human primary epidermal cells in
vitro could spontaneously occur within cultures of primary
keratinocytes processed according to protocols for allogenic
transplantation.
2.MaterialsandMethods
2.1. Tissue Procurement. Normal human skin samples were
obtained from the abdomen of four adult donors at the
Edouard Herriot Hospital (Lyon, France) after informed
consent of the patient. Donors were negative for HIV and
hepatitis serology.
2.2. Cell Isolation. For epithelial cells extraction, the epider-
mis and underlying dermis compartments were separated
by enzymatic digestion with thermolysin (overnight at 4◦C).
Epidermal cells were then isolated using a trypsin treatment
at 37
◦C. Four cell strains were extracted: KAL0501 was the
ﬁrst strain out of 200 presenting morphological changes,
KAL1152, KAL5045, and KAL0601 (one for each donor).
2.3. Cell Culture. Cells extracted from the epidermis
were ampliﬁed on human ﬁbroblast feeder layers until
maximum passage at 10000cells/cm2. Keratinocytes were
g r o w ni nG r e e nm e d i u m[ 11] consisting of a 3:1 mix-
ture of DMEM and Ham’s F12, respectively, supple-
mented with 10% FCS, 10ng/mL epidermal growth fac-
tor (EGF), 0.12IU/mL insulin, 0.4lg/mL hydrocortisone,
5lg/mL triiodo-L-thyronine, 24.3lg/mL adenine, and antibi-
otics.
2.4. Population Doubling (PD) and Growth Rate (GR). Cells
were seeded in three ﬂasks, were resuspended after about 14
days by trypsin treatment, and were counted ﬂask by ﬂask:
PD =
ln(cells number/CFU)
ln2
GR =
PD
Culture day number
(1)
2.5. Telomere Length Assay. To determine telomere length,
each strain was trypsinized at early (P1) and high pas-
sages (P5 or P17), and cell pellets were frozen at −80
◦C.
Genomic DNA was extracted with QIAamp DNA Mini
Kit and quantiﬁed by spectrophotometer. Telomere length
was determined using Telo TAGGG Telomere Length Assay.
Brieﬂy, DNA was digested by HinfI and RsaI enzymes,
DNA fragments were separated on agarose gel, trans-
ferred and hybridized with a telomere-speciﬁc digoxigenin-
(DIG-) labeled hybridization probe. After chemilumines-
cence detection, results were compared with DIG molecular
weight markers and two control DNAs (short and long
telomeres).
2.6. Chromosomal Analysis. For this experiment, cells were
cultured without feeder layer, in keratinocytes serum-free
medium supplemented with 25mg of bovine pituitary
extract and 2.5μg of EGF and antibiotics. Standard cyto-
genetic techniques using GTG and RHG-banding were
performed for chromosome examination. The analyses were
performed on 15 mitosis per strain.
2.7. Tp53 Sequencing. For mutation detection, DNA was
extracted from the four cell strains at passage 5.TP53
mutation analysis of exons 5–8 was performed by PCR-based
direct sequencing. The following forward (F) and reverse (R)
primers were used:
5F(5 TGTTCACTTGTGCCCTGACT3 ) 5R(5 CAG-
CCCTGTCGTCTCTCCAG3 )
6F(5 GCCTCTGATTCCTCACTGAT 3 ) 6R(5 TTA-
ACCCCTCCTCCCAGAGA 3 )
7F(CTTGCCACAGGTCTCCCCAA3 ) 7R(5 AGG-
GGTCAGCGGCAAGCAGA 3 )
8F(5 TTCCTTACTGCCTCTTGCTT 3 ) 8R(5 AGG-
CATAACTGCACCCTTGG 3 )
PCR conditions were as follows: for exons 5, 6, and 8,
denaturationat94
◦Cfor2minutesfollowedbyannealingfor
45 seconds at temperatures from 63
◦Ct o6 0
◦C, decreasing
0.5
◦C every 3 cycles and extension at 72
◦Cf o r1m i n u t e .
For exon 7, the selected condition was at a denaturationJournal of Skin Cancer 3
temperature of 95
◦C for 15 minutes followed by 94
◦Cf o r
30 seconds, annealing at 60
◦C for 30 seconds and extension
at 72
◦C for 1 minute. Aliquots of PCR products were
examined by electrophoresis on 2% agarose gel containing
ethidium bromide. PCR products were treated with 2μL
ExoSAP-IT at 37
◦C for 15 minutes followed by inactivation
at 80
◦C for 15 minutes and directly sequenced using Applied
Big Dye Terminator v1.1 cycle sequencing method on ABI
Prism 3100 Genetic Analyzer. The sequences obtained were
compared with the reference sequence, X54156, from Gen-
bank (http://p53.iarc.fr/TP53sequenceX54156.html). KRAS
mutations at codon 12 were analyzed by direct sequencing
of exon 1 as described elsewhere [12].
2.8. Detection of Epithelial-Mesenchymal Transition by West-
ern Blotting. Epithelial-mesenchymal transition (EMT) was
analyzed in keratinocyte cultures by measuring E-cadherin
and vimentin expression by Western blotting. Cultured
keratinocytes at early (P1) and high passages (P5) were
trypsinized and collected by centrifugation. The resulting
cell pellets were frozen at −80
◦C until analyses. Cells were
lysed in lysis buﬀer [50mM Tris HCl, pH 7.4, 250mM NaCl,
0.1% SDS, 0.5% Nonidet P-40 (NP40) containing protease
inhibitors (2μg/mL aprotinin, 500μM phenylmethylsulfonyl
ﬂuoride, 0.5μg/mL leupeptin, 1pg/mL pepstatin and 2mM
dithiothreitol)] and placed on ice for 30 minutes. Extracts
were subsequently centrifuged at 13000rpm for 15 minutes
at 4◦C. Supernatants were collected. Protein concentration
was determined using Bradford reagent. Thirtyμgo fp r o t e i n
extracts were separated on 7.5% SDS-PAGE and transferred
to Polyvinylidine diﬂuoride membranes by electroblotting.
Membranes were blocked with 5% dry milk in PBS-NP40
(0.05%) for 1 hour at room temperature and incubated
overnight with primary antibody diluted in 1% PBS -NP40
0.001% containing 1% dry milk. The following antibodies
were used: anti-E-cadherin clone 36 (Becton-Dickinson)
at a concentration of 0.25μg/ml, and antivimentin clone
V9 (Dako) at a dilution of 1/500. The membranes were
washed and incubated with peroxidase—conjugated sec-
ondary antimouse IgG antibody (Dako) at a dilution of
1/1000. The signals were detected by enhanced ECL kit
(Amersham).
2.9. Detection of Epithelial-Mesenchymal Transition by Im-
munoﬂuorescence. Cells were seeded and cultured on cov-
erslips in 12-well plates. At subconﬂuence, cells were ﬁxed
in 4% formaldehyde in PBS at room temperature for 15
minutes, rinsed by several changes of PBS. Cells were
permeabilized in Triton X100 1% in PBS for 5 minutes and
rinsed 3 times 5 minutes in PBS. Cells were blocked 30
minutes in FBS 10% at room temperature and subsequently
exposed to the primary antibodies raised against vimentin
(1/50), E-cadherin (1/250) for 2 hours and then to sec-
ondary goat antimouse (1/200) conjugated FITC for 1 hour.
The ﬂuorescent samples were examined with a Zeiss laser
scanning confocal microscope LSM 510 on Axiovert 200M.
The LSM 4.0 software was used for image acquisition and
analysis.
2.10. Soft Agar Assay. To determine the anchorage-
independent growth potential, the colony formation was
measured in soft agar. Cells of each strain were seeded into
75cm2 culture dishes and grown to 60%–70% conﬂuence.
0.75% and 0.45% agar media were prepared by mixing 1.5%
or 0.9% agar, respectively, and DMEM-HAM’s F12 2X with
20% FBS at a proportion 1:1. For the underlayer, 1.5mL
of 0.75% agar medium was added to 60mm wells. 293T
cells were used as positive control. They were generated by
transformation of cultures of normal human embryonic
kidney cells with sheared adenovirus and transfected by
SV40 Large T-antigen. These cells are able to grow in soft
agar and induced tumors in nude mice [13]. Cells at P5
for KAL 0601, 5045, 1152 and at P21 for KAL 0501 were
harvested by incubation in trypsin-EDTA, centrifuged at
1000rpm, and 5000 cells were suspended in 1.5mL of 0.45%
agar medium. Cell suspensions were then plated on the
underlayer of 0.75% agar. Agar plates were incubated at
37
◦C for 3 weeks. Cell colonies were scored using an inverted
microscope. As a rule, cell clusters measuring more than
80μm in greatest diameter were considered a colony. Each
soft agar assay was performed in triplicate.
2.11. Tumorigenicity Assay in Nude Mice. Female athymic
mice were selected aged 6 weeks (nu/nu genotype), from
Charles River (Lyon, France). After 3 weeks of quarantine
and acclimation for at least 3 days, mice were placed in an
animal facility compliant with regulation. The HPKIA cell
line at passage 345, a transformed cell line, was used as a
positive control, and HPKIA at passage 28, nontumorigenic,
were used as a negative control [14]. The keratinocytes and
the HPKIA tumor cells as reference strains were harvested,
washedwithserumfreemediumandcounted.Theinoculum
of each donor was subcutaneously injected in 3 nude mice
nearthescapula.Eachanimalreceived5×106 cellssuspended
in 0.2mL of PBS. The diﬀerent cell strains were injected
into separate groups. All the animals, including the reference
group, were observed and examined once a week for the
formation of nodules at the sites of injection. The period of
observation was three months, and at the end all animals
including the reference group were killed and autopsied.
The injection site area, kidney, lung, liver, and lymph node
were embedded in paraﬃnb l o c k sa n dw e r es u b j e c t e dt o
histopathological examination.
3. Results
3.1. Clonogenicity, Growth Rate and Population Doubling.
Cells KAL0601, 5045, and 1152 displayed normal growth
patterns, with homogenous clones composed of small cells
tightly attached to each other. This pattern did not change
with culture time or passaging. As expected, growth rate
(GR) and population doubling (PD) of these epidermal cells
decreased with passaging. Nevertheless, in P5, cells presented
no sign of crisis, and they could grow approximately until
the passage P10 before displaying a senescent phenotype
(Figure 1(b)).
Cells KAL0501 displayed a particular growth pattern.
Between passages P0 and P3, the morphology of these4 Journal of Skin Cancer
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Figure 1: Growth rates of keratinocytes in function of passages. (a):
growth rate of KAL 0501 from P1.
keratinocytes remained homogeneous with a characteristic
pavement shape and strong ties between cells (Figure 2(a)).
From P4 to P5, cells increased in size and assumed a
heterogeneous aspect. However, cells appeared to retain the
capacity to attach to each other. At P6 (Figure 2(b)), among
normal clones, some cells appeared to lose this attachment
capacity and, between P6 and P10, these cells of abnormal
morphology gradually invaded the culture. From P10 to
P18 (Figure 2(c)), cells either took a spindle-shaped aspect
when they had enough space to stretch out, or they appear
to revert to a pavement-like shape when short of space.
Furthermore, cells did not have a clonal growth in the latest
passages, but appeared to grow independently of each other
(Figure 2(d)), After settling in culture at P0, cells initially
showed a progressive decrease in their GR into P5 and then
presented signs of crisis. From P5 to P15 the cells bypassed
thecrisiswithanincreaseoftheirPDandGR.However,after
P15, their GR decreased slowly with passaging until death at
P25 (Figure 1(a)).
3.2. Telomere Length Assay. Telomere length was determined
for each strain at low (P1) and high passages (P5) for
KAL5045, 1152, 0601 and P17 for KAL050 (Table 1). For
all strains and whatever the passage analyzed, telomere
length was as long as the high telomere length control of
10.2Kb, in agreement with the fact that cells were in a
proliferating stage. For KAL 0501 at P17, however, telomere
length has decreased, consistent with the observation that
P2
(a)
P6
(b)
P15
(c)
P25
(d)
Figure 2: Pictures of KAL0501 in culture at diﬀerent passages
(x100). Primary keratinocytes KAL0501 are culture in green
medium on human feeder layer. Their morphology has changed
during the culture from passage P1 to P25.
Table 1: Telomere length of keratinocytes.
Cell strain Culture passage Telomere length (Kpb)
KAL 0501 1 10,9
KAL 0501 17 7,6
KAL 1152 1 10.6
KAL 1152 5 10.3
KAL 5045 1 10.6
KAL 5045 5 9.8
KAL 0601 1 9.8
KAL 0601 5 8.7
Control low telomere length 3.9
Control high telomere length 10.6
these cells had initiated a senescence process and were not
immortalized.
3.3. Chromosomal Analysis. Continuous serial passaging of
any cell type can eventually lead to chromosomal rearrange-
ments, sometimes resulting in a transformed phenotype. To
assess chromosomal stability, the karyotypes of KAL0601,
5045, and 1152 were evaluated at P3 and P4. They showed
normal karyotypes. As for KAL0501, no chromosome
abnormalities were detected at P1 or P10. However, some
structural abnormalities were detected at P20 (Figure 3).
These abnormalities include (i) an unbalanced translocation
involving4q32,and(ii)aduplicationat1q,oratranslocation
1q with another chromosome. In the case of chromosome
4q32, there was a deletion of the terminal q region, with
partial monosomy of this chromosome associated with a
partial trisomy of another chromosome. At P15, out of 15
mitoses analyzed, two presented the abnormality of the long
arm of the chromosome 4, but none of them presentedJournal of Skin Cancer 5
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Figure 3: Karyotype of KAL0501 at passage P20. At this passage,
two abnormalities are observed: an unbalanced translocation
4q32 and duplication 1q, or a translocation 1q with another
chromosome.
the chromosome 1 abnormality. Thus, we suggest that the
structural changes in 4q32 may have occurred between P10
and P15, whereas the changes in 1q may have taken place
later, between P15 and P20.
3.4. Somatic Alterations in Cancer-Related Pathways. Muta-
tions in the tumor suppressor gene TP53 are frequent
in human cancers. The TP53 database (www.iarc.fr/P53/)
compiles all mutations (somatic and inherited), as well as
polymorphisms, that have been reported in the published
literature since 1989. Exons 5 to 9 encode the DNA-binding
domain containing over 90% of all mutations in human
cancers and only a few SNPs (with a low frequency) occuring
in this region [15, 16]. No TP53 mutation or polymorphism
were detected in exons 5 to 9 in any of the four cell
strains, including KAL0501 at P5 and P20 (data not shown).
Mutationsincodon12ofKRASareoneofthemostcommon
mechanisms of activation of ras-related pathways in human
cancers. Sequencing of KRAS exon 1 (encompassing codon
12) did not reveal any mutation (data not shown). Similarly,
Western Blotting for eﬀectors of cell-cycle regulation such
as p16INK4a or Rb showed normal expression patterns in
all cell strains (data not shown). Therefore, none of the cell
strains presented with somatic alterations are characteristic
of the sequence of transformation of primary human
epithelial cells in vitro.
3.5. E-Cadherin and Vimentin Expression. In the course
of tumor progression, epithelial cells undergo epithelio-
mesenchymal transition (EMT) during which cells acquire
a ﬁbroblast-like phenotype and the ability for directed
migration and become dissociated from each other. These
events are the basis for invasion and metastasis of malignant
cells. EMT may occur at the very ﬁrst steps of cell transfor-
mation. To evaluate the occurrence of EMT, expression of E-
cadherin, a speciﬁc marker of epithelial cells, and expression
of vimentin, a speciﬁc marker of mesenchymal cells, were
investigated by western blotting on keratinocytes cultures at
passages 1 and 5 for KAL 0601, 5045 and 1152. The results
show that these cells express normal levels of E-cadherin but
lack vimentin expression, at both passages tested (data not
shown).
With respect to KAL0501, Figure 4(a) shows the results
obtained at passages P3, P6, P10, P15, and P16. The
expression of E-cadherin was normal from P3 to P6, was
strongly decreased at P10, and disappeared at P16. However,
it was still detectable until P15. As described above, until P6
KAL0501, it tended to adopt an epithelial-like morphology,
which may explain the persistence of E-cadherin expression.
In contrast, at P16, cells adopted a spindle-shape, with
intense vimentin expression. These results on KAL0501 were
conﬁrmed by immunoﬂuorescence (Figure 4(b)). showing
increasedexpressionofvimentinfromP3toP11andP15and
a progressive decrease of E-cadherin expression. In contrast
to Western Blotting, however, E-cadherin was not detected at
P15 suggesting that its expression was extremely low.
3.6. Soft Agar Assay. The test on soft agar allows the study of
cellscapacitytomultiplywithoutadheringtoasolidsupport,
a characteristic of transformed cells. This test was performed
on a transformed cell line (positive control, 293T cells), on
KAL0501 at passages P21, and on KAL 0601, 5045, and 1152
at passage P5. Results are presented in Figure 5.A f t e r2 1d a y s
of culture, it was observed that the positive control grew in
clones in agar and gave rise to 76 clones of at least 80μm
diameter per well after 5 weeks of culture. With respect to
KAL0501, no cells were able to adhere nor to form clones on
agar at P21. Neither could keratinocytes KAL0601, 5045, and
1152 grow on soft agar at P5.
3.7. Tumorigenicity and Experimental Metastasis Assay. Cul-
tured keratinocytes KAL0501 at P22, KAL5045 at P6,
KAL1152 at P5, and KAL0601 at P5 were injected in nude
mice, and tumor formation was monitored for at least
three months. As control, we used the HPV16-immortalized
keratinocyte cell line HPKIA which has acquired the ability
to form squamous cell carcinomas in nude mice after
gamma irradiation and long-term culturing in vitro. This
cell line expresses the oncoproteins E6 and E7 of human
papillomavirus type 16 (HPV16) [14]. Although becoming
immortal in vitro after a limited number of passages (P28),
HPKIA do not become tumorigenic in vivo until much later
passages (P345), allowing to use early or late passages of
these cells as negative or positive controls of tumorigenicity,
respectively. Three months after injection, all mice receiving
positive tumor control, developed rachitis and displayed
tumors at the injection points. In contrast, the 3 mice which
received the negative control did not reveal any tumors at the
injection site and were in good health. Mice that received 5
million of any of the four strains of keratinocytes, including
KAL0501 at P22, were in good health without rachitis
and did not present any tumor or nodule by palpation
throughout the observation period. Similarly, no tumor
was found at autopsy. After histopathological examination,6 Journal of Skin Cancer
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Figure 4: Expressionof vimentinand E-cadherin inKAL0501 at diﬀerentpassages in westernblot and immunoﬂuorescence. (a):E-cadherin
expression level of KAL 0501 decrease from P3 to P16 on contrary to vimentin expression which increase. (b): picture (confocal microscope
x25) of KAL0501 at P3, P11, and P15 cultured on monolayer. E-cadherin disappears progressively with the passage and vimentin appear at
P11.
Positive control P21 P5
293T KAL0501 KAL0601 KAL5045 KAL11052
Figure 5: Picture of soft agar assay (Microscope x10). The 4 cell strains are not able to grow in soft agar after 21 days of culture on contrary
to the positive control, the transformed human embryonic kidney 293T cells.
only mice injected with HPKIA at P345 displayed well-
diﬀerentiated keratinized squamous cell carcinoma followed
by lung metastasis. All other mice did not show any
microscopical evidence of tumors in situ or of metastasis.
4. Discussion
The spontaneous transformation of human skin ker-
atinocytes in vitro is a rare event. Since 1981, epidermal cell
sheets produced in vitro have been used for grafting in the
treatment of severely burned patients, and no cases of cancer
or occurrence of hyperproliferative lesions in relation with
the graft have been reported in the literature. Only one case
of squamous cell carcinoma of the skin occurring within
an area of grafted skin has been reported [17]. In this case,
however, the graft consisted of full-thickness skin taken from
the right postauricular area to resurface a lesion generated
by the incomplete excision of a basal cell carcinoma. In ourJournal of Skin Cancer 7
laboratory, primary keratinocytes have been cultured since
1988 with cultures developed from more than 200 diﬀerent
donors. The only example of a culture that spontaneously
developed a modiﬁed pattern in vitro is the cell strain
KAL0501 which is reported herein. This easily recognizable
abnormal cell morphology has led to its elimination from
clinical applications and all present investigations in order
to identify molecular markers that may help to detect
the earliest changes leading to transformation in primary
cultures of skin keratinocytes.
When compared to 3 other strains of keratinocytes
representative of the types of cultures routinely generated
in the laboratory, KAL0501 presented a speciﬁc phenotype.
Phenotypic changes were sporadically observed from P2.
The cell contours became refringent, unlike normal cells,
with dark contours when cultured on a feeder layer. Until
P5, however, cell growth decreased as for normal cultures.
However, in contrast to normal cultures, this decrease was
followedbyresumptionofgrowthwithlossofdiﬀerentiation
and appearance of vimentin expression. At this passage
P5, intercellular junctions became ineﬃcient and these cells
became unable to form cohesive epidermal sheets in culture
(data not shown). Despite detection of a chromosomal
translocation at 4q32, KAL0501 did not appear to develop a
capacity for long-term growth in vitro, did not form colonies
in soft agar, and did not form tumors after injection in nude
mice. We therefore conclude that despite EMT, phenotypic,
and chromosomal changes, KAL0501 did not undergo
immortalization in vitro and did not acquire tumorigenic
properties. Therefore, despite partial lack of diﬀerentiation
in vitro, KAL0501 does not exhibit the properties of a
transformed cell line.
In cell culture, it is extremely unlikely that during the
limited time of culture (4 passages maximum) keratinocytes
accumulate any mutations that could lead to the settlement
of a neoplastic phenotype. To conﬁrm this hypothesis, we
have analyzed TP53 (exons 5–8) and KRAS (exon 1) by
sequencingtwoofthegenesthataremostfrequentlymutated
in human epithelial tumors. Although our analyses do not
encompass the whole gene sequence, it covers all cancer-
related mutational hotspots as well as about 90% of the mis-
sense mutations reported for these genes in human cancer.
We did not ﬁnd evidence for such mutations, including in
the KAL0501 strain. Western blotting of proteins involved in
theRetinoblastomapathway,suchasRBitselfandp16INK4a,
did not reveal any abnormality at the protein level. Telomere
length in cells at P5 was also analyzed. Reduction of telomere
length is one of the hallmarks of progression of primary cells
in culture towards replicative senescence. All cell strains at
P5 presented with long telomeres, consistent with the notion
that at P5 they are still at the proliferative stage. KAL0501
cells were not diﬀerent from other cells in this respect, and
their telomere length decreased at high passage, consistent
with the fact that these cells initiated a senescence process
and were not immortalized. To ensure that transformation
may not occur as the result of a contamination of these cells
by oncogenic human papillomaviruses, the viral DNA for
serotypes 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58,
59, 66, 68, 70, 73, and 82 were investigated by multiplex PCR
method combined with DNA microarray primer extension
[18]. None of the strains, including KAL0501 showed
evidence of papillomavirus infection at passages 1, 3, 5, and
10 (data not shown). Overall, we conclude that none of the
fourstrainspresentedobviouscharacteristicsofearlystepsof
transformation.
Despite the absence of immortalization in vitro and
of tumorigenicity in vivo, the KAL0501 strain showed
remarkable changes in its diﬀerentiation pattern, with a
capacity to undergo at least some of the phenotypic changes
associated with EMT. The molecular bases for this property
are unknown and may deserve further investigations. Inter-
estingly, the karyotype of KAL0501 reveals a translocation
inducing a loss of the terminal part of chromosome 4q,
which may have occurred at around passage 10–15 in this
particular strain. This area is a common area of loss in many
cancers and developmental diseases. In particular, it has
recently been proposed as a possible area for genes involved
in SHFM (Split Hand and Foot Malformation Syndrome),
a developmental defect characterized by abnormal epider-
mal to mesenchyme interactions during morphogenesis
[19]. It is tempting to speculate that this region may
contain some gene(s) or relevance for the regulation of
EMT.
With clinical applications in mind, it is essential to make
sure that the protocols used for producing epidermal sheets
for transplantations are safe not only from the point of view
of the risk of contamination and of immune response, but
also in terms of long-term cell stability. Our results concur
with the notion that human keratinocytes are extremely
stable in vitro and may not experience transforming muta-
tions during the short time of ex vivo expansion (4 passages
maximum). However, as demonstrated by the case of the
KAL0501 strain, signiﬁcant morphological changes may
occur, during which some cultures may adopt phenotypes
demonstrating altered diﬀerentiation and enhanced growth
properties.Suchchangesareeasytodetectastheirﬁrsteﬀects
are to modify the normal clonal growth pattern, and prevent
the formation of tight epithelial sheets. They may therefore
be detected and eliminated before grafting.
5. Conclusion
Transformation of human epithelial cells in vitro is a rare
event and diﬃcult, in part due to the tight control over
genetic and genomic stability and to the limited replicative
lifespan of primary human cells. In the present study,
we demonstrate that diﬀerent strains of primary human
keratinocytes do not show any evidence of transformation
and tumorigenicity even if one of them, KAL0501, develops
an altered growth pattern with features that resemble
epidermal to mesenchyme transition. Of note, this strain is
the only one presenting such a phenotype among a series of
over 200 independent cultures developed in our laboratory
since 1988. Therefore, we conclude that the protocols used
for generating keratinocyte sheets for transplantations are
reasonably safe with respect to their long-term stability and
lack of tumorigenicity. Nevertheless, alterations in cell shape,
adhesion and growth patterns may occur in rare instances,8 Journal of Skin Cancer
calling for special attention before using cultures for clinical
use.
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